Loading clinical trials...

Impact of Omega 3 in Treatment of Inappropriate Sinus Tachycardia | Clinical Trials | Clareo Health

COMPLETEDNA

Impact of Omega 3 in Treatment of Inappropriate Sinus Tachycardia

NCT07138131•Benha University

Summary

This study aimed to evaluate the effect of omega-3 supplementation on heart rate (HR) control and heart rate variability (HRV) in children with inappropriate sinus tachycardia (IST).

Detailed Description

Inappropriate sinus tachycardia (IST) is a is a common disease of the autonomic nervous system in children in which tachyarrhythmia characterized by a persistent increase in resting sinus rate or disproportionate elevation of heart rate (HR) with minimal physiological effort accompanied by wide ranging symptoms including palpitations, fatigue, presyncope, and exercise intolerance it could cause lead to total disability in severe cases .it also takes a chronic course with Significant adverse effects on quality of life.

Eligibility

Age

12 - 16 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Age from 12 to 16 years.
•Both sexes.
•Patients diagnosed with inappropriate sinus tachycardia (IST).
•Patients with resting heart rate (HR) ≥100 bpm (sitting) and/or 24-hour average HR ≥90.

Exclusion Criteria

•Structural heart disease.
•Patients receiving antiarrhythmic medication.
•Patients with a prior history of arrhythmias such as paroxysmal supraventricular tachycardia (PSVT) or sick sinus syndrome, or orthostatic hypotension.
•Secondary conditions such as anemia, infection, or hyperthyroidism.

Locations (1)

Benha University

Banhā, Al-Qalyubia, Egypt

Key Dates

Start Date

October 1, 2023

Primary Completion Date

September 1, 2024

Completion Date

September 1, 2024

Last Updated

August 22, 2025

Enrollment

ACTUAL participants

Conditions

Omega 3TreatmentInappropriate Sinus Tachycardia

Interventions

Omega 3

DRUG

Standard follow-up

OTHER

A Trial of Chinese Traditional Medicine Combining With Intradermal Acupuncture for Treating Precocious Puberty

NCT06510764

Precocious PubertyTreatment+2 more

View study

RECRUITINGPHASE1

Venetoclax Basket Trial for High Risk Hematologic Malignancies

NCT05292664

Myelodysplastic Syndromes, de NovoMyelodysplastic Syndromes, Secondary+9 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 22, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Impact of Omega 3 in Treatment of Inappropriate Sinus Tachycardia

Inclusion Criteria

Exclusion Criteria

A Trial of Chinese Traditional Medicine Combining With Intradermal Acupuncture for Treating Precocious Puberty

Venetoclax Basket Trial for High Risk Hematologic Malignancies

Effect Clomiphene vs Clomiphene Along With Pioglitazone on Ovarian Stimulation Rate

Human Amniotic-Derived Mesenchymal Stem Cell Therapy for Calciphylaxis

University of Iowa Interventional Psychiatry Service Patient Registry

Virtual Reality-Based Mindfulness as an Adjunct to Treatment as Usual in Treatment-Resistant Depression